CAS: 2220184-50-7
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | CDK12-IN-3 REF: 54-BUP12531CAS: 2220184-50-7 | ≥98% | 1.454,00 €~5.775,00 € | Vie 09 May 25 |
 | CDK12-IN-3 REF: 3D-VND18450CAS: 2220184-50-7 | Min. 95% | A consultar | Vie 20 Jun 25 |
 | CDK12-IN-3 REF: TM-T14990CAS: 2220184-50-7 | 99.85% | A consultar | Jue 26 Jun 25 |
Ref: 54-BUP12531
| 25mg | 1.454,00 € | ||
| 50mg | 2.431,00 € | ||
| 100mg | 3.216,00 € | ||
| 200mg | 3.973,00 € | ||
| 500mg | 5.775,00 € |
Entrega estimada en Estados Unidos, el Viernes 9 de Mayo de 2025
CDK12-IN-3
CAS:2220184-50-7
Please enquire for more information about CDK12-IN-3 including the price, delivery time and more detailed …
Fórmula:
C23H28F2N8O
Pureza:
Min. 95%
Peso molecular:
470.5 g/mol
Ref: 3D-VND18450
| 10mg | 868,00 € | ||
| 25mg | 1.334,00 € | ||
| 50mg | 2.078,00 € |
Entrega estimada en Estados Unidos, el Viernes 20 de Junio de 2025
CDK12-IN-3
CAS:2220184-50-7
CDK12-IN-3 is a CDK12 inhibitor with anti-tumor activity and can be used for the study …
Fórmula:
C23H28F2N8O
Pureza:
99.85%
Forma y color:
Solid
Peso molecular:
470.52
Ref: TM-T14990
| 1mg | 130,00 € | ||
| 5mg | 311,00 € | ||
| 10mg | 512,00 € | ||
| 25mg | 1.074,00 € | ||
| 50mg | 1.795,00 € | ||
| 100mg | 2.375,00 € | ||
| 1mL*10mM (DMSO) | 344,00 € |
Entrega estimada en Estados Unidos, el Jueves 26 de Junio de 2025
